IPO - HeartBeam, Inc.

Form Type: 8-K

Filing Date: 2025-02-26

Corporate Action: Ipo

Type: New

Accession Number: 000121390025017245

Filing Summary: HeartBeam, Inc. completed a public offering on February 14, 2025, raising gross proceeds of $10,000,000 through the sale of 5,882,353 shares of common stock at a price of $1.70 per share. The underwriter was granted an Over-allotment Option to purchase an additional 882,353 shares, which was partially exercised on February 21, 2025, for 864,033 shares. The closing of the Over-allotment Shares occurred on February 25, 2025, generating approximately $1.5 million in gross proceeds. A press release announcing the closing of the Over-allotment Option was issued on February 25, 2025, and is included as Exhibit 99.1 in this report.

Document Link: View Document

Form Type: 424B5

Filing Date: 2025-02-14

Corporate Action: Ipo

Type: New

Accession Number: 000121390025013706

Filing Summary: HeartBeam, Inc. is offering 5,882,353 shares of its common stock at an offering price of $1.70 per share through a firm commitment underwriting. The total offering amount is approximately $10 million. The last reported sale price of HeartBeam's common stock was $2.24 per share on February 12, 2024. The underwriter has an option to purchase up to 882,353 additional shares for over-allotments within 45 days post-offering. The offering intends to support HeartBeam's operations focused on innovative cardiac monitoring solutions, particularly targeting patients with coronary artery disease (CAD) using its proprietary cable-free ECG technology which recently received FDA clearance. The HeartBeam System synthesizes a 12-lead ECG from captured signals and aims to enhance remote patient monitoring and diagnostics in the wake of changing healthcare delivery dynamics. HeartBeam's initiatives are backed by ongoing AI developments aimed at improving diagnostic accuracy and efficiency in arrhythmia detection, making strides in addressing market needs for portable cardiac health solutions.

Document Link: View Document

Form Type: 424B5

Filing Date: 2024-12-23

Corporate Action: Ipo

Type: New

Accession Number: 000121390024111343

Filing Summary: HeartBeam, Inc. is initiating an offering of common stock valued at $10,000,000, the specifics of which are not finalized. The offering will follow a firm commitment basis and the shares will not be sold until the registration statement with the SEC is declared effective. As of the latest reported data, the aggregate market value of outstanding common stock held by non-affiliates is approximately $71.15 million. The offering pricing details, including underwriting discounts and expenses, are yet to be disclosed. The underwriters have been granted an over-allotment option for additional shares post-offering. HeartBeam aims to address the growing sector of telehealth solutions for cardiac monitoring with its HeartBeam System, which has recently received FDA clearance. This innovative device is designed to allow for real-time monitoring of cardiac conditions outside clinical facilities, leveraging new technology to enhance patient care. The company plans to capitalize on the increasing demand for remote health management solutions, which is expected to grow significantly in the coming years due to rising healthcare costs and the shift towards connected medical devices.

Document Link: View Document